share_log

HC Wainwright & Co. Reiterates Buy on Calumet, Maintains $25 Price Target

Benzinga ·  Aug 13 02:56  · Ratings

HC Wainwright & Co. analyst Amit Dayal reiterates Calumet (NASDAQ:CLMT) with a Buy and maintains $25 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment